1. Home
  2. RAYA vs XRTX Comparison

RAYA vs XRTX Comparison

Compare RAYA & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$2.73

Market Cap

4.2M

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

N/A

Current Price

$0.58

Market Cap

4.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RAYA
XRTX
Founded
2019
2011
Country
China
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
RAYA
XRTX
Price
$2.73
$0.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
124.6K
44.3K
Earning Date
04-17-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,101,325.00
N/A
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.78
N/A
52 Week Low
$3.13
$0.51
52 Week High
$736.99
$1.41

Technical Indicators

Market Signals
Indicator
RAYA
XRTX
Relative Strength Index (RSI) 34.31 45.91
Support Level $3.63 $0.57
Resistance Level $4.20 $0.60
Average True Range (ATR) 0.35 0.03
MACD -0.09 0.00
Stochastic Oscillator 0.00 45.16

Price Performance

Historical Comparison
RAYA
XRTX

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: